NCT06904612 is a clinical trial of Micronutrient fortified iodized salt in Neural Tube Defects, sponsored by Hydrocephalus and Neuroscience Institute.

Who is sponsoring NCT06904612?

NCT06904612 is sponsored by Hydrocephalus and Neuroscience Institute.

What drugs are being tested in NCT06904612?

Interventions in NCT06904612: Micronutrient fortified iodized salt.

What condition does NCT06904612 study?

NCT06904612 studies Neural Tube Defects, Folic Acid Deficiency, Spina Bifida, Anencephaly-Spina Bifida, B12 Deficiency Vitamin, Anemia, Iron Deficiency Anaemia Due to Dietary Causes.

Is NCT06904612 still recruiting?

NCT06904612 is currently completed. Last updated 14 July 2025.

Last reviewed 2025-07-14 · How we verify

NCT06904612

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Using Iodized Salt to Improve Serum Folate, B12 and Iron Levels

Completed Last updated 14 July 2025

What this trial tests

trial testing Micronutrient fortified iodized salt in Neural Tube Defects in 200 participants. Completed in 30 November 2022.

Timeline

1 June 2022

Primary endpoint
30 November 2022

30 November 2022

Quick facts

Lead sponsor	Hydrocephalus and Neuroscience Institute
Status	Completed
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 June 2022
Primary completion	30 November 2022
Estimated completion	30 November 2022
Sites	2 locations across United States, India

Drugs / interventions tested

Micronutrient fortified iodized salt

Conditions studied

Neural Tube Defects — all drugs for Neural Tube Defects →
Folic Acid Deficiency — all drugs for Folic Acid Deficiency →
Spina Bifida — all drugs for Spina Bifida →
Anencephaly-Spina Bifida — all drugs for Anencephaly-Spina Bifida →

Sponsor

Hydrocephalus and Neuroscience Institute

Who can join

Adults 18 to 45, female only, with Neural Tube Defects or Folic Acid Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Question: How effective is fortified iodized salt in increasing serum concentrations of folate, B12 and iron among non-pregnant and non-lactating women of reproductive age? Hypothesis: Micronutrient fortified iodized salt can increase serum levels (of folate, B12 and iron) and serve as a policy consideration in salt fortification with both iodine and other micronutrients to reduce serious and fatal birth defects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Neural Tube Defects

Currently open trials in the same condition.

NCT04770805 — In Utero Fetoscopic Repair Program for Sacral Myelomeningoceles and Mye-LDM · NA · active not recruiting
NCT03856034 — Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele · NA · recruiting

Other Hydrocephalus and Neuroscience Institute trials

Trials by the same sponsor.

NCT06174883 — Salt-FA to Increase Folate Levels · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06904612 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hydrocephalus and Neuroscience Institute
Last refreshed: 14 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06904612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing